Clincosm LogoSign in Get a demo

Major Depressive Disorder

Showing NaN - NaN of 50
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDD, Treatment Resistant Depression, Depression Trial in United States (AXS-05)

Completed
Has Results
  • Major Depressive Disorder
  • +2 more
  • AXS-05 (dextromethorphan and bupropion) oral tablets
  • Phoenix, Arizona
  • +50 more
Sep 16, 2022

MDD Trial in San Antonio (repetitive transcranial magnetic stimulation, robotic arm)

Terminated
Has Results
  • Major Depressive Disorder
  • repetitive transcranial magnetic stimulation
  • robotic arm
  • San Antonio, Texas
    Ikare, Mood, Trauma, Recovery Clinic
Aug 5, 2022

MDD Trial in Australia, United States (PRAX-114, Placebo)

Completed
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +30 more
Jul 20, 2022

MDD Trial in United States (Levomilnacipran ER, Fluoxetine, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • Levomilnacipran ER
  • +2 more
  • Little Rock, Arkansas
  • +50 more
Mar 1, 2022

MDD Trial in Worldwide (SPD489 (Lisdexamfetamine dimesylate) + Antidepressant)

Terminated
Has Results
  • Major Depressive Disorder
  • SPD489 (Lisdexamfetamine dimesylate) + Antidepressant
  • Birmingham, Alabama
  • +211 more
Jun 9, 2021

MDD Trial in United States (Vortioxetine, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +78 more
Dec 16, 2020

Depression, MDD Trial in Canada, United States (Levomilnacipran ER, Placebo)

Completed
Has Results
  • Depression
  • Major Depressive Disorder
  • Levomilnacipran ER
  • Placebo
  • Beverly Hills, California
  • +34 more
Dec 23, 2019

MDD Trial in Canada, United States (Vilazodone)

Completed
Has Results
  • Major Depressive Disorder
  • Birmingham, Alabama
  • +55 more
Sep 10, 2019

MDD Trial in Australia, Canada, United States (High Dose ALKS 5461, Low Dose ALKS 5461, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • High Dose ALKS 5461
  • +2 more
  • Birmingham, Alabama
  • +48 more
Aug 2, 2019

MDD Trial in United States (Vortioxetine)

Completed
Has Results
  • Major Depressive Disorder
  • Costa Mesa, California
  • +24 more
Jun 14, 2019

MDD Trial in United States (ALKS 5461, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • ALKS 5461
  • Placebo
  • Tucson, Arizona
  • +26 more
Apr 26, 2019

MDD Trial in United States (Antidepressant + , Antidepressant + cariprazine (0.1-0.3 mg/day), Antidepressant + cariprazine (1-2

Completed
Has Results
  • Major Depressive Disorder
  • Antidepressant + placebo
  • +2 more
  • Phoenix, Arizona
  • +40 more
Feb 12, 2019

MDD Trial in Mexico, United States (desvenlafaxine succinate sustained release, fluoxetine, )

Completed
Has Results
  • Major Depressive Disorder
  • desvenlafaxine succinate sustained release
  • +2 more
  • Dothan, Alabama
  • +42 more
Jan 2, 2019

MDD Trial in Worldwide (ALKS 5461)

Completed
Has Results
  • Major Depressive Disorder
  • ALKS 5461
  • Birmingham, Alabama
  • +157 more
Nov 21, 2018

MDD Trial in Worldwide (Placebo, Cariprazine)

Completed
Has Results
  • Major Depressive Disorder
  • Garden Grove, California
  • +71 more
Mar 29, 2018

MDD Trial in Worldwide (LY2216684, Placebo, SSRI)

Completed
Has Results
  • Major Depressive Disorder
  • Irvine, California
  • +62 more
Mar 17, 2018

Depression, MDD Trial in San Antonio (ketamine)

Terminated
Has Results
  • Depression
  • Major Depressive Disorder
  • San Antonio, Texas
    University Hospital
Jan 22, 2018

MDD Trial in United States (vilazodone)

Completed
Has Results
  • Major Depressive Disorder
  • Garden Grove, California
  • +37 more
Aug 22, 2017

MDD Trial in Worldwide (duloxetine, Placebo, fluoxetine)

Completed
Has Results
  • Major Depressive Disorder
  • Costa Mesa, California
  • +58 more
Sep 7, 2017

MDD Trial in Chile, United States (DVS SR)

Completed
Has Results
  • Major Depressive Disorder
  • DVS SR
  • Birmingham, Alabama
  • +35 more
Jun 28, 2017

MDD Trial in Chile, Mexico, United States (Desvenlafaxine Succinate Sustained-Release, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • Desvenlafaxine Succinate Sustained-Release
  • Placebo
  • Birmingham, Alabama
  • +41 more
Jan 30, 2017

MDD Trial in United States (80 Milligrams NSI-189, Placebo, 40 Milligrams NSI-189)

Unknown status
  • Major Depressive Disorder
  • 80 Milligrams NSI-189
  • +2 more
  • Garden Grove, California
  • +12 more
Feb 23, 2017

MDD Trial in Mexico, United States (DVS SR)

Completed
Has Results
  • Major Depressive Disorder
  • DVS SR
  • Dothan, Alabama
  • +34 more
Dec 16, 2016

NSI-189, With Out-Patients With Major Depressive Disorder

Unknown status
  • Major Depressive Disorder
  • Garden Grove, California
  • +11 more
Sep 20, 2016

Treatment-Resistant Depression Registry

Completed
Has Results
  • Major Depressive Disorder
    • Tucson, Arizona
    • +54 more
    Dec 22, 2015